AVENUE THERAPEUTICS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

AVENUE THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $2.86 million for the year ending 2025.

  • AVENUE THERAPEUTICS, INC. showed an increase of +10.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from AVENUE THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2015 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2025: $2.86 million | Fiscal year 2024: $2.59 million | Fiscal year 2023: $1.78 million | Fiscal year 2022: $6.71 million | Fiscal year 2021: $3.76 million | Fiscal year 2020: $3.13 million | Fiscal year 2019: $8.75 million | Fiscal year 2018: $2.67 million | Fiscal year 2017: $11.78 million | Fiscal year 2016: $197.0 thousand | Fiscal year 2015: $14.0 thousand | Fiscal year 2015: $0.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: